Results 201 to 210 of about 554,314 (294)

Buprenorphine/naloxone - one formulation that doesn't fit all: a case report. [PDF]

Harm Reduct J
Braun HM, Taylor JL, Axelrath S.
europepmc   +1 more source

Descriptive molecular pharmacology of the δ opioid receptor (DOR): A computational study with structural approach. [PDF]

PLoS One
Goode-Romero G, Dominguez L.
europepmc   +1 more source

Naloxone distribution amidst shifting drug use patterns: Insights from a needs-based syringe services program. [PDF]

Drug Alcohol Depend
Eger WH, Paltin D, Ross JD, Bailey K, Nguyen AV, Solomon EM, Bartholomew TS, Han BH, Bazzi AR.   +8 more
europepmc   +1 more source

A case of severe opioid and methamphetamine use disorder in a 14 year old. [PDF]

Addict Sci Clin Pract
Allami N, O'Connor K, Bagley SM.
europepmc   +1 more source

Comparison of Midazolam and Diazepam for Sedation in Patients Undergoing Double-Balloon Endoscopic Retrograde Cholangiopancreatography: A Propensity Score-Matched Analysis. [PDF]

J Clin Med
Fujii Y, Matsumoto K, Matsumi A, Miyamoto K, Uchida D, Horiguchi S, Tsutsumi K, Mitsuhashi T, Otsuka M.   +8 more
europepmc   +1 more source

Involvement of central opioid and melanocortin receptors in spexin-induced hypophagia following intracerebroventricular injection in neonatal broiler chicks. [PDF]

BMC Vet Res
Badri M, Alimohammadi S, Zendehdel M, Hassanpour S.   +3 more
europepmc   +1 more source

Managing xylazine-involved overdoses in a community harm reduction setting: lessons from Tijuana, Mexico. [PDF]

Harm Reduct J
Bufanda LP, Montoya AG, Carrillo BT, Tejeda MAG, Segovia LA, Calderón-Villarreal A, Friedman JR.   +6 more
europepmc   +1 more source